IL289513A
(en )
2022-03-01
A pharmaceutical preparation for administration through the nose
SG11202008732VA
(en )
2020-10-29
A pharmaceutical composition for anaemia
ZA202007890B
(en )
2022-06-29
Stable pharmaceutical compositions for pressurized metered dose inhalers
IL289619A
(en )
2022-03-01
A pharmaceutical preparation containing a tetrahydropyrazolopyrimidine compound
IL282032A
(en )
2021-05-31
Pharmaceutical preparations containing RPL554 in HFA-134A for administration by inhalation
PT3781126T
(pt )
2022-06-07
Composição farmacêutica de pó seco para inalação compreendendo uma hormona da tiróide
ZA202006371B
(en )
2022-12-21
A pharmaceutical dry powder composition for inhalation comprising a thyroid hormone
PL3621682T3
(pl )
2021-04-19
Inhalator suchego proszku
IL292100A
(en )
2022-06-01
A dry powder preparation that can be inhaled for pulmonary diseases
SG11202103851PA
(en )
2021-05-28
Dry pharmaceutical composition for inhalation
IL279478A
(en )
2021-01-31
A preparation containing a somatostatin analogue for radiopharmaceutical use
PL422716A1
(pl )
2019-03-11
Inhalator pojedynczej dawki suchego proszku
EP3999036C0
(en )
2023-11-08
ORODISPERSIBLE POWDER COMPOSITION CONTAINING A TRIPTAN
GB202113921D0
(en )
2021-11-10
Dry powder medicament inhaler
GB202111658D0
(en )
2021-09-29
Dry powder medicament inhaler
GB202200986D0
(en )
2022-03-09
Dry powder medicament inhaler
GB202311884D0
(en )
2023-09-13
Dry powder inhaler
IL287930A
(en )
2022-01-01
Inhaler with double measurement
EP4034207C0
(en )
2024-03-13
DRY POWDER INHALATOR FOR PULMONARY OR NASAL ADMINISTRATION
IL279481A
(en )
2021-01-31
A preparation containing a somatostatin analogue for radiopharmaceutical use
IL289437A
(en )
2022-02-01
Pharmaceutical preparations for glucagon and glp-1 agonist co-peptides
SG10201912063PA
(en )
2021-07-29
A pharmaceutical formulation
GB201909280D0
(en )
2019-08-14
Solid dose formulation
GB201706109D0
(en )
2017-05-31
A composition for oral administration